Arvinas Stock Price

0.00 (0.0%)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Arvinas Inc ARVN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 74.34 04:01:49
Open Price Low Price High Price Close Price Prev Close
Bid Price Ask Price Spread News
68.89 150.00 81.11 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 74.34 USD

Arvinas Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.64B 48.99M 38.16M $ 21.80M $ - -3.01 -24.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 387.90k 2.80%

more financials information »

Arvinas News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ARVN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week80.9983.4772.8177.29952,690-6.65-8.21%
1 Month65.5384.9064.8276.08603,6018.8113.44%
3 Months63.5184.9056.638370.14423,93910.8317.05%
6 Months79.8792.7756.5974.33480,083-5.53-6.92%
1 Year32.5492.7719.6855.61612,15641.80128.46%
3 Years21.0092.7710.1945.59400,45053.34254.0%
5 Years21.0092.7710.1945.59400,45053.34254.0%

Arvinas Description

Arvinas Inc is a United States-based private biopharmaceutical company focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. Its pipeline candidates include metastatic castration-resistant prostate cancer, metastatic ER-breast cancer, additional oncology indications, tauopathies, and other neurodegenerative diseases.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.